Reckitt Benckiser Healthcare (UK) Ltd. has won dismissal from a lawsuit by 35 states and the District of Columbia alleging that several companies conspired to fix the price of the opioid treatment drug suboxone.
The win comes at a time when the drugmaker, which also manufactures household products like condoms and baby formula, has weathered a cyberattack and cut its sales forecasts twice. Exiting the states’ antitrust case should help Reckitt Benckiser’s bottom line given the complexity and cost of discovery in such cases. According to Bloomberg Law’s Litigation Analytics, antitrust litigation is 14.5 percent of the company’s overall ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.